Accessible Search Form           Advanced Search

Genomics: Gene Discovery and Clinical Applications for Cardiovascular, Lung, and Blood Diseases

Genomics: Gene Discovery and Clinical Applications for Cardiovascular, Lung, and Blood Diseases Banner

Welcome


The National Heart, Lung, and Blood Institute supports large-scale genomic research programs and consortia that seek to discover the genetic determinants of cardiovascular, lung and blood diseases and translate genomic findings into prediction, prevention and treatment of disease. Several recent NHLBI programs have supported large-scale, collaborative genomic research studies, including: genome-wide association studies (GWAS) and projects to develop tools for analysis of genomics data; genotyping and DNA sequencing for genetic studies; pharmacogenetic research studies; proteomic and other 'omic’ research programs; large-scale sequencing studies that utilize next-generation technologies in targeted and genome-wide sequencing; and use of induced pluripotent stem cells to model diseases for next-generation genetic association studies.

Genomics: Gene Discovery and Clinical Applications for Cardiovascular, Lung, and Blood Diseases will focus on cutting edge findings in recent and ongoing genome-wide research studies, highlighting novel discoveries, including results from large-scale collaborative studies, new analysis techniques, novel directions in functional genomics, and translational research. A broad cross-section of experts in the field, including researchers involved in molecular biology and molecular genomics, bioinformatics, and genetic epidemiology, as well as physicians specializing in heart, lung and blood diseases, will discuss the emerging science and the translation of these advances to the clinic.

Among the featured NHLBI Genome Programs will be the Candidate Gene Association Resource (CARe), SNP Health Association Resource (SHARe), Enhancing Development of Genome-Wide Association Methods (ENDGAME), PharmacoGenetics Research Network (PGRN), SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic Data (STAMPEED), Proteomics Program, Exome Sequencing Program (ESP), Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Sequencing Program, and the Next-Generation Genetic Association Studies Program

The goals of this symposium are:

  • To provide cutting edge information about recent scientific advances from NHLBI genome research programs
  • To inform attendees about NHLBI and NIH genomics programs and consortia and available resources
  • To catalyze collaborations and stimulate ideas for translational research
  • To hold an open discussion about new opportunities for human genomics research


Confirmed Speakers

Goncalo Abecasis, D. Phil., University of Michigan School of Public Health
Donna K. Arnett, Ph.D., M.S.P.H., University of Alabama at Birmingham School of Public Health
Eric Boerwinkle, Ph.D., University of Texas Health Science Center
Aravinda Chakravarti, Ph.D., Johns Hopkins University School of Medicine
Chad Cowan, Ph.D., Harvard Medical School / Massachusetts General Hospital
Santhi Ganesh, M.D., University of Michigan
Ray E. Hershberger, M.D., University of Miami Miller School of Medicine
Sekar Kathiresan, M.D., Massachusetts General Hospital
Leslie Lange, Ph.D., University of North Carolina at Chapel Hill School of Medicine
Richard P. Lifton, M.D., Ph.D., Yale University
Suzanne M. Leal, Ph.D., Baylor College of Medicine
Carole Ober, Ph.D., University of Chicago
Stuart H. Orkin, M.D., Harvard Medical School / Children’s Hospital Boston
Len A. Pennacchio, Ph.D., Department of Energy Joint Genome Institute
Thomas Quertermous, M.D., Stanford University School of Medicine
Daniel J. Rader, M.D., University of Pennsylvania School of Medicine
Kenneth Rice, Ph.D., University of Washington
Dan M. Roden, M.D., Vanderbilt Medical Center
David A. Schwartz, M.D., National Jewish Health
Christine E. Seidman, M.D., Harvard Medical School
Alan R. Shuldiner, M.D., University of Maryland School of Medicine
Susan B. Shurin, M.D., National Heart, Lung, and Blood Institute
Edwin K. Silverman, M.D., Ph.D., Brigham and Women’s Hospital
Cristen J. Willer, Ph.D., University of Michigan


Program Organizing Committee


Chair: Christopher J. O'Donnell, M.D., M.P.H., National Heart, Lung, and Blood Institute

Co-Chair: Deborah Nickerson, Ph.D., University of Washington
               Stephen S. Rich, Ph.D., University of Virginia Center for Public Health Genomics

Deborah Applebaum-Bowden, Ph.D., National Heart, Lung, and Blood Institute
Eric Boerwinkle, Ph.D., University of Texas Health Science Center, Houston
L. Adrienne Cupples, Ph.D., Boston University School of Public Health
Weiniu Gan, Ph.D., National Heart, Lung, and Blood Institute
Cashell E. Jaquish, Ph.D., National Heart, Lung, and Blood Institute
Alan M. Michelson,M.D., Ph.D., National Heart, Lung, and Blood Institute
Carole Ober, Ph.D., University of Chicago
Stuart H. Orkin, M.D., Harvard Medical School and Dana Farber Cancer Institute
Dina N. Paltoo, Ph.D., National Heart, Lung, and Blood Institute
George Papanicolaou, Ph.D., National Heart, Lung, and Blood Institute
Scott T. Weiss, M.D., Harvard Medical School and Brigham and Women's Hospital